Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 209, Issue 5, Pages 711-720
Publisher
Oxford University Press (OUP)
Online
2013-08-14
DOI
10.1093/infdis/jit411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
- (2013) Melanie A. Thompson et al. ANNALS OF INTERNAL MEDICINE
- Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
- (2013) Janne Estill et al. PLoS One
- Treatment outcomes after 7 years of public-sector HIV treatment
- (2012) Matthew P. Fox et al. AIDS
- Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings
- (2012) Olawale Ajose et al. AIDS
- Outcomes Following Virological Failure and Predictors of Switching to Second-line Antiretroviral Therapy in a South African Treatment Program
- (2012) Victoria Johnston et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
- (2012) Matthew P. Fox et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Second-Line Antiretroviral Therapy
- (2012) Richard A. Murphy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa
- (2012) K. C. E. Sigaloff et al. JOURNAL OF INFECTIOUS DISEASES
- Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa
- (2012) Julie H. Levison et al. PLoS One
- Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome
- (2012) Victoria Johnston et al. PLoS One
- A novel HIV treatment model using private practitioners in South Africa
- (2012) Craig Innes et al. SEXUALLY TRANSMITTED INFECTIONS
- Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa
- (2011) Kim C.E. Sigaloff et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study
- (2011) Laura J. Else et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?
- (2011) Catherine Orrell et al. ANTIVIRAL THERAPY
- Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients
- (2011) Roos E Barth et al. ANTIVIRAL THERAPY
- Low Lopinavir Plasma or Hair Concentrations Explain Second-Line Protease Inhibitor Failures in a Resource-Limited Setting
- (2011) Gert Uves van Zyl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Development of Antiretroviral Drug Resistance
- (2011) Mark A. Wainberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa
- (2010) Ziad El-Khatib et al. AIDS
- Triple-Class Virologic Failure in HIV-Infected Patients Undergoing Antiretroviral Therapy for Up to 10 Years
- (2010) ARCHIVES OF INTERNAL MEDICINE
- Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
- (2010) Mison Dahab et al. BMC PUBLIC HEALTH
- High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa
- (2010) Matthew P Fox et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries
- (2010) Mar Pujades-Rodríguez JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiretroviral Adherence Interventions: Translating Research Findings to the Real World Clinic
- (2010) Jane M. Simoni et al. Current HIV/AIDS Reports
- Dynamics of NRTI Resistance Mutations during Therapy Interruption
- (2009) Maria Trignetti et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
- (2009) Annemarie M.J. Wensing et al. ANTIVIRAL RESEARCH
- Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
- (2009) Laurence Ahoua et al. BMC INFECTIOUS DISEASES
- Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression
- (2009) V Cambiano et al. HIV MEDICINE
- Adherence to Antiretroviral Therapy Assessed by Drug Level Monitoring and Self-Report in Cameroon
- (2009) Charles Kouanfack et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited Settings
- (2009) Alessandro Cozzi‐Lepri et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More